Scientific articles 29 Apr 2025 Fexinidazole as a new oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense: A prospective, open-label, single-arm, Phase II–III, non-randomised study The Lancet Global Health
Scientific articles 29 Apr 2025 Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: A phase IIIb, prospective, open-label, non-randomised, cohort study The Lancet Global Health
News 25 Apr 2025 Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi
Press releases 24 Apr 2025 Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease
In the media 23 Apr 2025 Race against time: New treatment for deadly HIV complication enters trials Daily Nation
Press releases 23 Apr 2025 DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease
Scientific articles 21 Apr 2025 A balancing act: Navigating the advantages and challenges of pioneering mycetoma treatment in Sudan – A landmark trial by the Mycetoma Research Center PLOS Neglected Tropical Diseases
Scientific articles 17 Apr 2025 Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted network The Lancet Child & Adolescent Health
In the media 17 Apr 2025 New treatment for deadly HIV-linked meningitis enters phase II trial The Standard
In the media 17 Apr 2025 Un nouveau traitement contre la méningite à cryptocoque, en phase d’essai RTS
In the media 16 Apr 2025 Accord historique à l’OMS sur la préparation et la lutte contre les futures pandémies AFP
In the media 16 Apr 2025 Luz verde para un “histórico” tratado mundial contra pandemias impulsado por la OMS El País
Press releases 1 Oct 2020 DNDi welcomes GHIT Fund support for Phase I trial of novel treatment for cutaneous leishmaniasis
Press releases 29 Sep 2020 DRC: The Ministry of Health and DNDi launch a project designed to facilitate access to new treatments against sleeping sickness
Press releases 28 Sep 2020 Fundación MEDINA, DNDi, and Institut Pasteur Korea announce new funding from “la Caixa” Health Research for research partnership to discover new natural products against leishmaniasis and Chagas disease
Press releases 4 Sep 2020 Innovative single-dose oral sleeping sickness treatment to be co-developed by Sanofi and DNDi partnership
Press releases 13 May 2020 DNDi short film about new treatment for sleeping sickness awarded Grand Prix at inaugural WHO film festival
Press releases 14 Apr 2020 Up to 45,000 people living with Chagas disease in the US at risk of severe COVID-19 complications
Press releases 13 Apr 2020 Marking World Chagas Day for the first time to help give visibility to this neglected disease
Press releases 2 Apr 2020 Coalition launched to accelerate research on the prevention and treatment of COVID-19 in low- and middle-income countries
Press releases 25 Feb 2020 Novartis and DNDi to collaborate on the development of a new oral drug to treat visceral leishmaniasis
Press releases 5 Dec 2019 Brazil’s Ministry of Health and CNPq to invest in researching new treatments for leishmaniasis and Chagas disease
Press releases 28 Nov 2019 Public-private partnership launched to develop new drugs for roundworm infections
Press releases 27 Nov 2019 Research for new drugs against neglected diseases and malaria in Brazil to receive funding boost totaling BRL 43.5 million
Press releases 25 Nov 2019 Efforts to register new hepatitis C treatment in Malaysia receive support from Pharmaniaga
Press releases 25 Nov 2019 DNDi receives $29 million to fast-track the development of drugs to help eliminate sleeping sickness and river blindness
Press releases 20 Nov 2019 Study shows that African eye worm threatens elimination of river blindness